Cumulus Oncology Ltd. raised $50M in a series A funding round to develop novel drug targets for clinical use.
Cumulus Oncology Ltd. raised $50M in a series A funding round to develop novel drug targets for clinical use.
09/03/24, 12:52 AM
Location
edinburghMoney raised
$50 million
Industry
biopharma
therapeutics
pharmaceutical
biotechnology
health care
Round Type
series a
Cumulus Oncology Ltd. is in the process of raising a $50 million series A round aimed at sourcing and developing new drug targets from academia. This funding will support their ongoing efforts in clinical development and startup creation.
Company Info
Location
edinburgh, scotland, united kingdom
Additional Info
Cumulus Oncology Ltd. is a biopharmaceutical company focused on sourcing novel drug targets emerging from academia and developing them for clinical use. The company specializes in creating startups from its discoveries. Cumulus is currently raising funds to support its growth and development initiatives. Their work is centered around cancer treatment advancements.